Management of CML patients
Management of CML patients treated with ponatinib in real-life setting: Experience shared by Italian prof. Massimo Breccia
The purpose of the meeting is to provide an understanding of how ponatinib works when used outside clinical triats
12:00 – 12:05 Introduction
Sr. Medical Advisor, Daniel Thunström, lncyte Biosciences
12:05 – 12:45 Management of CML patients treated with ponatinib in real-life
Prof. Massimo Breccia, Sapienza
Unlversity of Rome, ltaly
12: 45 – 13:00 Questions and discussions
(Moderator TBD)
